Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

Related Articles by Review for PubMed (Select 21472845)

1.

Prevalence and patterns of nitrosatable drug use among U.S. women during early pregnancy.

Brender JD, Kelley KE, Werler MM, Langlois PH, Suarez L, Canfield MA; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2011 Apr;91(4):258-64. doi: 10.1002/bdra.20808. Epub 2011 Apr 6.

2.

Genotoxic and carcinogenic risk to humans of drug-nitrite interaction products.

Brambilla G, Martelli A.

Mutat Res. 2007 Jan-Feb;635(1):17-52. Epub 2006 Dec 6. Review.

PMID:
17157055
3.

Inhibition of nitrosamine formation by ascorbic acid.

Tannenbaum SR, Wishnok JS, Leaf CD.

Am J Clin Nutr. 1991 Jan;53(1 Suppl):247S-250S. Review.

4.

Demographic and psychosocial characteristics of substance-abusing pregnant women.

Hans SL.

Clin Perinatol. 1999 Mar;26(1):55-74. Review.

PMID:
10214543
5.

Significance of in vivo formation of N-nitroso compounds.

Lijinsky W.

Oncology. 1980;37(4):223-6. Review.

PMID:
7003452
6.

Understanding U.S. fertility: continuity and change in the National Survey of Family Growth, 1988-1995.

Mosher WD, Bachrach CA.

Fam Plann Perspect. 1996 Jan-Feb;28(1):4-12. Review.

7.

Valproic acid monotherapy in pregnancy and major congenital malformations.

Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, de Jong-van den Berg LT; EUROCAT Antiepileptic Study Working Group.

N Engl J Med. 2010 Jun 10;362(23):2185-93. doi: 10.1056/NEJMoa0907328. Review.

8.

Births by younger and older mothers in a population with late and regulated childbearing: Finland 1991.

Hemminki E, Gissler M.

Acta Obstet Gynecol Scand. 1996 Jan;75(1):19-27. Review.

PMID:
8560992
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk